Urinary Orosomucoid (α-1-Acid Glycoprotein) As A Single Potential Biomarker Through PET Assay for Diagnosis of Early Onset Sepsis in Neonates: A Review

Alfiani Zukhruful Fitri Rifa’i¹, Hanifah Nabilah¹, Idznika Nurannisa Wibowo¹, Reny I’tishom^2*

Abstract

Neonatal sepsis is a condition in which bacteria are present in an infant’s sterile body fluids. It is considered one of the most common causes of infant death, with nearly one million deaths per birthday and approximately 2 million deaths in the first week of life. To aid in the early diagnosis of neonatal sepsis, a potential new biomarker for early neonatal sepsis called orosomucoid (ORM) or α1-glycoprotein (α1AGP) in urine is being evaluated because of its greater accuracy than current diagnostic tools. Combined with particle turbidity analysis (PET), neonatal sepsis can be diagnosed in an immediate, sensitive, specific and non-invasive manner. The early local increase in urinary ORM in sepsis suggests that it could be a new promising marker of sepsis and an important part of routine laboratory and clinical practice.

Keywords

Biomarker; orosomucoid; u-ORM; -1-acid glycoprotein; α-1AGP; sepsis; particle-enhanced turbidimetric test; neonates

Cite This Article

Rifa’i, A. Z. F., Nabilah, H., Wibowo, I. N., I’tishom, R. (2022). Urinary Orosomucoid (α-1-Acid Glycoprotein) As A Single Potential Biomarker Through PET Assay for Diagnosis of Early Onset Sepsis in Neonates: A Review. International Journal of Scientific Advances (IJSCIA), Volume 3| Issue 1: Jan-Feb 2022, Pages 27-33, URL: https://www.ijscia.com/wp-content/uploads/2022/01/Volume3-Issue1-Jan-Feb-No.212-27-33.pdf

Volume 3 | Issue 1: Jan-Feb 2022